{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Drug-Induced+Movement+Disorder&page=2", "query": { "condition": "Drug-Induced Movement Disorder", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Drug-Induced+Movement+Disorder&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T10:36:02.377Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03062033", "title": "Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tardive Dyskinesia" ], "interventions": [], "intervention_types": [], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2017-04-04", "completion_date": "2018-08", "has_results": false, "last_update_posted_date": "2017-11-22", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 34, "location_summary": "Little Rock, Arkansas • Anaheim, California • Long Beach, California + 29 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Gatos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03062033" }, { "nct_id": "NCT06218719", "title": "Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tardive Dyskinesia" ], "interventions": [], "intervention_types": [], "sponsor": "Power Life Sciences Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2025-02", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2024-01-23", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06218719" }, { "nct_id": "NCT04857359", "title": "Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Parkinson Disease", "Dyskinesia, Drug-Induced", "Dyskinesias" ], "interventions": [ { "name": "Dipraglurant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Addex Pharma S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "30 Years to 85 Years" }, "enrollment_count": 25, "start_date": "2021-08-06", "completion_date": "2022-08-15", "has_results": false, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Fresno, California • Irvine, California + 38 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04857359" }, { "nct_id": "NCT02195700", "title": "Aim to Reduce Movements in Tardive Dyskinesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Tardive Dyskinesia" ], "interventions": [ { "name": "SD-809", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Auspex Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 117, "start_date": "2014-06", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 32, "location_summary": "Tuscaloosa, Alabama • Anaheim, California • Glendale, California + 29 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02195700" }, { "nct_id": "NCT03944447", "title": "Outcomes Mandate National Integration With Cannabis as Medicine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Pain", "Chronic Pain Syndrome", "Chronic Pain Due to Injury", "Chronic Pain Due to Trauma", "Fibromyalgia", "Seizures", "Hepatitis C", "Cancer", "Crohn Disease", "HIV/AIDS", "Multiple Sclerosis", "Traumatic Brain Injury", "Sickle Cell Disease", "Post Traumatic Stress Disorder", "Tourette Syndrome", "Ulcerative Colitis", "Glaucoma", "Epilepsy", "Inflammatory Bowel Diseases", "Parkinson Disease", "Amyotrophic Lateral Sclerosis", "Chronic Traumatic Encephalopathy", "Anxiety", "Depression", "Insomnia", "Autism", "Opioid-use Disorder", "Bipolar Disorder", "Covid19", "SARS-CoV Infection", "COVID-19", "Corona Virus Infection", "Coronavirus" ], "interventions": [ { "name": "Cannabis, Medical", "type": "DRUG" }, { "name": "RYAH-Medtech Inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "OMNI Medical Services, LLC", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 200000, "start_date": "2018-12-01", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2022-06-02", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 17, "location_summary": "Boca Raton, Florida • Bradenton, Florida • Fort Lauderdale, Florida + 13 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03944447" }, { "nct_id": "NCT03495024", "title": "Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Tobacco Smoking", "Tardive Dyskinesia", "Parkinsonism" ], "interventions": [ { "name": "Varenicline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Corporal Michael J. Crescenz VA Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 10, "start_date": "2019-01-01", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2019-03-22", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03495024" }, { "nct_id": "NCT00164242", "title": "Treatment of Tardive Dyskinesia With Galantamine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tardive Dyskinesia" ], "interventions": [ { "name": "Galantamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Caroff, Stanley N., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2002-01", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2005-09-14", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00164242" }, { "nct_id": "NCT01429207", "title": "Capturing Parkinson's Disease Medication Side Effects During Daily Activities", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson's Disease", "Dyskinesia" ], "interventions": [], "intervention_types": [], "sponsor": "Great Lakes NeuroTechnologies Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 15, "start_date": "2011-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-06-29", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01429207" }, { "nct_id": "NCT06997198", "title": "Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tardive Dyskinesia", "Intellectual Disability", "Developmental Disabilities" ], "interventions": [ { "name": "Deutetrabenazine Oral Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 25, "start_date": "2026-06-22", "completion_date": "2027-10-01", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06997198" }, { "nct_id": "NCT02761707", "title": "Biomarkers in Neural Disorders", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson's Disease", "Alzheimer's Disease", "Progressive Supranuclear Palsy", "Essential Tremor", "Multiple System Atrophy", "Drug Induced Parkinson's Disease", "Diffuse Lewy Body Disease", "Myasthenia Gravis", "Spinal Cord Injuries" ], "interventions": [ { "name": "Electrical Brainstem Responses", "type": "OTHER" }, { "name": "Olfactory Tests", "type": "OTHER" }, { "name": "Visual Deprivation", "type": "OTHER" }, { "name": "Peripheral Nerve Stimulation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 54, "start_date": "2016-06", "completion_date": "2019-07-16", "has_results": false, "last_update_posted_date": "2019-07-18", "last_synced_at": "2026-07-24T10:36:02.377Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02761707" } ] }